Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yun-Peng Liao"'
Autor:
Yan Ma, Ya Zhou, Yu-Xi Su, Jia-Hui Zhu, Yun-Peng Liao, Qin Li, Bai-Cheng He, Han Wang, Fu-Shu Li, Ying Hu
Publikováno v:
Journal of Cellular Biochemistry. 119:9462-9473
Bone morphogenetic protein 9 (BMP9), as one of the most potent osteogenic factors, is a promising cytokine for bone tissue engineering. Wnt11 can regulate the development of the skeletal system and is related to high bone mass syndrome. However, the
Autor:
Jia-Hui Zhu, Bai-Cheng He, Yan Ma, Ke Wu, Rong-Xing Liu, Wen-Yan Ren, Hai-Tao Jiang, Yun-Peng Liao, Han Wang, Wen-Juan Sun
Publikováno v:
International Journal of Oncology. 51:907-917
Colorectal cancer (CRC) is the second leading cause of cancer death. Hence, there is a great need to explore new efficacious drugs for the treatment of CRC. Honokiol (HNK), a natural product extracted from magnolia bark, processes various biological
Autor:
Rui Deng, Jia-Hui Zhu, Bai-Cheng He, Zhong-Liang Deng, Hai-Tao Jiang, Yun-Peng Liao, Mao Nie, Han Wang, Cheng-Cheng Ran
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 191
Glucocorticoid-Induced Osteoporosis (GIOP) is a prevalent clinical complication caused by large dose administration of glucocorticoids, such as Dexamethasone (Dex) and Prednisone. GIOP may lead to fractures and even Osteonecrosis of the Femoral Head
Autor:
Yun-Peng Liao, Bai-Cheng He, Yan Ma, Jia-Hui Zhu, Han Wang, Wei-Min Du, Fu-Shu Li, Yu-Xi Su, Qin Li, Ya Zhou, Ying Hu
Publikováno v:
Journal of cellular biochemistry. 120(6)
Bone morphogenetic protein 9 (BMP9) is one of the most potent osteogenic factors, which may be a potential candidate for bone tissue engineering. However, the osteogenic capacity of BMP9 still need to be further enhanced. In this study, we determined
Autor:
Bai-Cheng He, Jia-Hui Zhu, Yan Ma, Yun-Peng Liao, Han Wang, Ke Wu, Rong-Xing Liu, Wen-Juan Sun, Wen-Yan Ren, Xue-Lian Hu
Publikováno v:
International journal of oncology. 53(5)
Colon cancer is a prevalent malignancy affecting the gastrointestinal tract. Oridonin (ORI) is a promising chemotherapeutic drug used in the treatment of colon cancer. In this study, we examined the anticancer activity of ORI against colon cancer and
Publikováno v:
Journal of cellular biochemistry. 119(7)
Pioglitazone/metformin adduct is a novel compound synthesized from pioglitazone and metformin combined at a molar mass ratio of 1:1. The aim of this study was to investigate the effects of pioglitazone/metformin adduct on high glucose-induced insulin
Autor:
Jia-Hui Zhu, Yuxi Su, Wen-Yan Ren, Bai-Cheng He, Yan Ma, Han Wang, Fang He, Yun-Peng Liao, Zhong‐Liang Deng, Jin Cui, Hua Gan
Publikováno v:
Journal of cellular biochemistry. 119(3)
Vascular calcification is a notable risk factor for cardiovascular system. High phosphate can induce calcification in vascular smooth muscle cells (VSMCs), but the detail mechanism underlying this process remains unclear. In the present study, we det
Autor:
Wen-Yan Ren, Jia-Hui Zhu, Jin Wang, Yu-Hua Zeng, Qian-Zhao Chen, Ying Shao, Ming Huang, Bai-Cheng He, Lin-Yun Zhou, Yun-Peng Liao, Han Wang, Yang Li, Fang He, Ke Wu
Publikováno v:
Oncology reports. 38(1)
Colon cancer is common worldwide and accounts for the significant cancer related morbidity and mortality in patients. Although extensive advancement has been made in colon cancer treatment and diagnosis in the last decades, there is still a giant gap
Autor:
RONG-XING LIU, WEN -YAN REN, YAN MA, YUN-PENG LIAO, HAN WANG, JIA-HUI ZHU, HAI-TAO JIANG, KE WU, BAI-CHENG HE, WEN-JUAN SUN
Publikováno v:
International Journal of Oncology; Sep2017, Vol. 51 Issue 3, p907-917, 11p
Autor:
YU-HUA ZENG, LIN-YUN ZHOU, QIAN-ZHAO CHEN, YANG LI, YING SHAO, WEN-YAN REN, YUN-PENG LIAO, HAN WANG, JIA-HUI ZHU, MING HUANG, FANG HE, JIN WANG, KE WU, BAI-CHENG HE
Publikováno v:
Oncology Reports; Jul2017, Vol. 38 Issue 1, p456-464, 9p